Syros Pharmaceuticals, Inc.

SYRSOTCHealthcare● Active

$0.00

$-0.00(-50.00%)

Market Cap$5366

P/E Ratio—

52W High$0.04

52W Low$0.0001

Avg Volume12K

Open$0.00

Beta1.27

Overview

Syros Pharmaceuticals, Inc. (SYRS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · SYRS · as of Mar 27, 2024

Latest filing snapshot

-49-41.88%vs prior year

Syros Pharmaceuticals, Inc. (SYRS) employee data is sourced from the annual SEC 10-K filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2023-12-31·Full-time · Global

Total Employees

Change (1Y)

-49

Growth % (1Y)

-41.88%

Revenue / Employee

$146.1K

Net Income / Employee

$-2.42M

Market Cap

$0M

SYRS Employee Count

2016 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2024-03-27	2023-12-31	68	-49	-41.88%
2023-03-02	2022-12-31	117	-7	-5.65%
2022-03-15	2021-12-31	124	+21	+20.39%
2021-03-04	2020-12-31	103	+20	+24.10%
2020-03-05	2019-12-31	83	+7	+9.21%
2019-03-07	2018-12-31	76	-199,924	-99.96%
2018-03-12	2017-12-31	200,000	+0	+0.00%
2017-03-20	2016-12-31	200,000	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

SYRS

Syros Pharmaceuticals, Inc.YOU

68$0M #2

NKGN

NKGen Biotech, Inc. Common Stock

Dermata Therapeutics, Inc.

8$1M #5

COEP

Coeptis Therapeutics, Inc.

5$58M #6

KTTA

Pasithea Therapeutics Corp.

4$4M #7

NUVO

Holdco Nuvo Group D.G Ltd. Ordinary Shares

N/A$6M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · SYRS peer comparison

About SYRS employees

SYRS Employees · Headcount

Syros Pharmaceuticals, Inc. (SYRS) employee data is sourced from the annual SEC 10-K filing. As of 2023, Syros Pharmaceuticals, Inc. had 68 full-time employees globally. Full-time employees only. Global consolidated headcount.

Syros Pharmaceuticals, Inc. employs 68 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $146,118, reflecting the company's operational efficiency.

Syros Pharmaceuticals, Inc.'s workforce decreased by 49 (41.88%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Syros Pharmaceuticals, Inc.'s revenue per employee of $146,118 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

SYRS Employees · 5 questions

As of the latest SEC 10-K filing (2023), Syros Pharmaceuticals, Inc. had 68 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Syros Pharmaceuticals, Inc. employee counthow many employees does Syros Pharmaceuticals, Inc. haveSYRS total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-03-27